Burnaby company granted Health Canada licence to produce 'magic mushroom' medicine
At Burnaby’s Albert Labs, it’s science meets nature. On the walls, you’ll find posters of various mushrooms next to scientific formulas, symbolizing the company's mission to develop mental health medicine derived from natural substances. The small team of around 20 employees recently received a Health Canada license to further pursue its work in producing psilocybin from mushrooms.
“Oh, it’s very big,” said Ali Gulamhusein, chief development officer for Albert Labs.
“That licence grants us the ability to produce, manufacture, export and import psilocybin.”
Gulamhusein refers to psilocybin as the magic medicine of the magic mushroom. The company also operates in the U.K. and Portugal, and plans to begin clinical trials in the U.K. this fall.
“(The) first early indications that we’re targeting is cancer-related anxiety,” said Gulamhusein, who adds that the company also hopes to treat people with depression, anxiety and PTSD.
Gulamhusein says the process involves isolating the psilocybin from the root and bio-engineering the drug in a controlled setting to help ensure consistency.
The company’s CEO says studies of the treatment have been overwhelmingly positive, calling psilocybin a potential game changer when it comes to mental illness therapy.
“One dose – and associated psychotherapy – cures anxiety for many months, and in some cases, permanently,” said Dr. Michael Raymont.
But it’s currently only available for Canadians with special permission from doctors. Christine Parlee lives with terminal stage four cancer and was granted permission for treatment to help ease her severe anxiety.
“It was phenomenal, probably one of the best experiences of my life to be honest,” said Parlee via Zoom from her home in Duncan.
“To say it changed me down to the bottom of my core is putting it mildly.”
One expert tells CTV News that despite high demand from patients, it could take two to three years before psychedelics become a common, more accessible treatment.
“I think there’s a lot of work to be done in training of professionals in understanding this new paradigm in mental health treatment,” said Dr. Devon Christie, senior lead of psychedelic programs at Numinus.
Meanwhile, if all goes well in the U.K., Albert Labs hopes to have its drug ready for trial in Canada by 2023.
CTVNews.ca Top Stories
Western University researchers unlock potential 'cure' for ALS
New research out of London, Ont.'s Western University is shedding light on a potential cure for ALS, in which the targeting of the interaction between two proteins can halt or fully reverse the disease's progression.
Police release 3D images of young child found in an Ontario river two years ago
Police have released a three-dimensional image of a young child whose remains were discovered in the Grand River in Dunnville, Ont. almost two years ago.
A child killer legally changed his name in B.C. The province is trying to stop that from happening again
The BC NDP have tabled legislation aimed at stopping people who have committed certain heinous acts from changing their names.
Collapsed Baltimore bridge span comes down with a boom after crews set off chain of explosives
Crews conducted a controlled demolition Monday to break down the largest remaining span of the collapsed Francis Scott Key Bridge in Baltimore.
CN Railway suspends service on some networks due to wildfires
Canadian National (CN) Railway suspended service on its network between Fort St. John and Fort Nelson in B.C. and north of High Level, Alta., due to wildfires, the company said on Monday.
Kamala Harris drops F-bomb during White House live-stream
U.S. Vice-President Kamala Harris used a profanity on Monday while offering advice to young Asian Americans, Native Hawaiians and Pacific Islanders about how to break through barriers.
Mortgage companies could intensify the next recession, U.S. officials warn
U.S. officials worry the next recession could be intensified by a cascading series of failures in the mortgage industry caused by crashing home prices, frozen financial markets and soaring delinquencies.
What Michael Cohen said on the stand in Trump hush money case
The star prosecution witness in Donald Trump's hush money trial took the stand Monday with testimony that could help shape the outcome of the first criminal case against an American president.
Security video caught admitted serial killer disposing of bodies in Winnipeg garbage bins
Security video caught admitted serial killer Jeremy Skibicki on multiple late-night outings, disposing of body parts in nearby garbage bins and dumpsters in the middle of the night.